Suscribirse

Conservative management of polymicrobial peritonitis complicating peritoneal dialysis—a series of 140 consecutive cases - 02/09/11

Doi : 10.1016/S0002-9343(02)01364-5 
Cheuk-Chun Szeto, MD a, , Kai-Ming Chow, MBChB a, Teresa Yuk-Hwa Wong, MBChB a, Chi-Bon Leung, MBChB a, Philip Kam-Tao Li, MBBS a
a Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China 

*Requests for reprints should be addressed to Cheuk-Chun Szeto, MD, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China

Abstract

Purpose

Because polymicrobial peritonitis is believed to be caused by bowel perforation in peritoneal dialysis patients, surgical exploration is often recommended. However, there is recent evidence that antibiotic therapy may be a safe alternative.

Methods

We studied 140 consecutive episodes of dialysis-related polymicrobial peritonitis from January 1995 to June 2001. All episodes were treated primarily with intraperitoneal antibiotics. When there was no response, the Tenckhoff catheter was removed, usually after about 10 days of treatment. Laparotomy was performed only when there was clinical suspicion of surgical pathology.

Results

Ninety patient-episodes (64%) responded to antibiotics alone by day 10; 56 patients (40%) had complete cure with no relapse in 4 months. Nine patients (6%) died within 2 days. Laparotomy was performed in 8 patients who did not respond by day 10, but only 3 had underlying surgical disease (strangulated hernia, ischemic colitis, and colonic cancer). In a multivariate logistic regression analysis, age and the presence of fungus, anaerobes, or Pseudomonas species in the dialysis fluid were independent predictors of poor primary response; and presence of fungus was the only independent predictor of failure to cure in 4 months.

Conclusion

Most patients with dialysis-related polymicrobial peritonitis responded to antibiotic therapy, and surgical exploration was needed only in a few patients. A careful examination of isolated organisms may help in identifying patients who need Tenckhoff catheter removal or surgical intervention.

El texto completo de este artículo está disponible en PDF.

Esquema


 This study was supported in part by The Chinese University of Hong Kong research account 6901031.


© 2002  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 113 - N° 9

P. 728-733 - décembre 2002 Regresar al número
Artículo precedente Artículo precedente
  • Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the women’s ischemia syndrome evaluation (WISE)
  • C.Noel Bairey Merz, Marian B Olson, B.Delia Johnson, Vera Bittner, T.Keta Hodgson, Sarah L Berga, Glenn D Braunstein, Carl J Pepine, Steven E Reis, George Sopko, Sheryl F Kelsey
| Artículo siguiente Artículo siguiente
  • Bone mass and the risk of prostate cancer: The Framingham study
  • Yuqing Zhang, Douglas P Kiel, R.Curtis Ellison, Arthur Schatzkin, Joanne F Dorgan, Bernard E Kreger, L.Adrienne Cupples, David T Felson

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.